- How To
- Cigar Info
- Site Info
Currently viewing the tag: "op-ed"
A greater appreciation of the distinct uniqueness of e-cigarettes, as compared with cigarettes, will help to accelerate innovative research on e-cigarettes and other electronic devices, leading to new theoretical models and behavioral measures.
Many of the biggest causes of NCDs – like tobacco and junk foods – have powerful industries working on their sides. But so many lives are at stake – and there really is no excuse for inaction. So it is encouraging to see you all here, and the steps you ta
Some of us will doff our hats at an age in which the cigarette was elegance, then edge, then transgression. And some of us will bow our heads to the time when we were young, and thought ourselves immortal.
Today’s offices are full of people staring at their screens at open-plan desks with headphones jammed unsociably over their ears to block out noise. And, thankfully, far fewer smoke. Design solutions Thus we are seeing a number of design “solutions” to m
r. The sad thing here is that the average smoking patron on the boardwalk doesn’t have a lobbyist to speak for him. The small shops who rely on the daily foot traffic in the summer don’t have influence even with their own elected officials in many cases.
Although eliminating the tax on vaping products would be ideal, the proposed tax change would help soften the burden New Jersey vape shop owners would face come October 1 if the current tax goes into effect. Rather than imposing draconian taxes on device
Stopping e-cigarette use, such as with JUUL devices and other products, among vulnerable age groups will require stronger regulatory actions and sustained efforts by policy makers, medical professionals, public health activists, and the manufacturers who
Last week the News and Tribune featured an article by Elizabeth DePompei about a local pipe smoking champion. The piece evoked memories of my own pipe smoking days, and my experiences with tobacco…simply to call the national quit line (1-800-QUIT-NOW)
Lauren Lempert listened in to the presentations and scientific discussion of the RJR application to market Camel Snus as a modified (i.e., reduced) risk tobacco product on September 14, 2018. After that session, she and I prepared this public comment, wh
We should continue to restrict sales of all tobacco-related products to minors, and more heavily tax the highest risk products. The FDA should amend its regulatory scheme from one designed to eliminate entry of any fundamentally new product into the mark